CEP-1347 (KT7515), a Semisynthetic Inhibitor of the Mixed Lineage Kinase Family
Anna C. Maroney(AbbVie (United States)), Jeffry L. Vaught(Kyowa Kirin (Japan)), Zhiheng Xu(Roche (China)), John T. Durkin(Albert Einstein College of Medicine), Lloyd A. Greene(Columbia University Irving Medical Center), George Gessner(Brandywine Photonics (United States)), Mary J. Savage(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sheryl L. Meyer(NRG Oncology), Thomas J. Connors(Columbia University Irving Medical Center), Thelma S. Angeles, James P. Finn
Cited by 207
Related Papers
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2017|1.3k
Rapamycin Protects against Neuron Death in<i>In Vitro</i>and<i>In Vivo</i>Models of Parkinson's Disease
|Journal of Neuroscience|2010|464
Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells
|Journal of Medicinal Chemistry|2005|430